Thompson Tamar (CIK 1839248) reported 5 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-17). Recent activity: Sell CPRX (3,773 shares), Sell RNAM (6,692 shares), Buy CPRX (1,413 shares), Buy CPRX (947 shares), Buy RNA (6,692 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-17 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Sell | 3,773 | $118,850 |
| 2026-02-27 | Avidity Biosciences, Inc. (RNAM) | Director | Sell | 6,692 | $0 |
| 2025-12-10 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 1,413 | $0 |
| 2025-11-24 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | Buy | 947 | $0 |
| 2025-06-12 | Avidity Biosciences, Inc. (RNA) | Director | Buy | 6,692 | $0 |
Source: SEC Form 4 filings · as of 2026-07-17